Ascorbic acid Withdrawn Phase 2 Trials for Severe Thermal Injury, Greater Than 20% TBSA Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01587261Vitamin C for Severe Thermal Injuries